Robert L. Roberts - Concepedia

Author

Robert L. Roberts

Also Known As

R L Roberts, R Roberts, R. L. ROBERTS, R. L. Roberts, R. Roberts, R.L. Roberts, ROBERT L. ROBERTS, Robert L Roberts, Robert L. Roberts, Robert L.Roberts

124

Publications

Citations

H-Index

109

Concepts

All Affiliations

University of California, Los Angeles UCLA Medical Center Mattel Children's Hospital UCLA Health Cedars-Sinai Medical Center

About

Robert L. Roberts is an author at University of California, Los Angeles specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	2K
2	Health Sciences	6	6	217
3	Engineering	4	4	198
4	Natural Sciences	1	1	179
5	Public Health	1	1	35

Robert L. Roberts

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome Alejandro Aruffo, Mary Farrington, Diane Hollenbaugh, Cell Activated T CellsAllergyAutoimmune DiseaseT-regulatory CellImmunology	1993	824
Relationship of protein phosphorylation to the activation of the respiratory burst in human neutrophils. Defects in the phosphorylation of a group of closely related 48-kDa proteins in two forms of chronic granulomatous disease. Nobuyuki Okamura, J T Curnutte, Robert L. Roberts, Journal of Biological Chemistry Isoelectric PointsImmunologyPathologyInflammationHematology	1988	179
Eosinophils Preferentially Use Bromide to Generate Halogenating Agents Arthur N. Mayeno, A J Curran, Robert L. Roberts, Journal of Biological Chemistry EngineeringLipid PeroxidationStimulated EosinophilsOrganic ChemistryHalogenating Agents	1989	148
Role of Candidate Modifier Genes on the Phenotypic Expression of Hypertrophy in Patients with Hypertrophic Cardiomyopathy Ramón Brugada, Marcel E. Lechin, Guiling Zhao, Journal of Investigative Medicine	1997	98
Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation. J T Curnutte, Roger L. Berkow, Robert L. Roberts, Journal of Clinical Investigation Nadph OxidaseLipid PeroxidationImmunologyPathologyDermatology	1988	98
Clinical Features and Current Management of Chronic Granulomatous Disease Christopher B. Forrest, J R Forehand, Richard A. Axtell, Hematology/Oncology Clinics of North America GranulocyteChronic Granulomatous DiseaseHistopathologyPathologyMedicine	1988	95
Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy E. Warwick Daw, S. N. Chen, Grazyna Czernuszewicz, Human Molecular Genetics	2007	78
Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease Richard L. Wasserman, A M Irani, James M. Tracy, Clinical & Experimental Immunology	2010	68
Reevaluation of cytochrome b and flavin adenine dinucleotide in neutrophils from patients with chronic granulomatous disease and description of a family with probable autosomal recessive inheritance of cytochrome b deficiency Yoshiyuki Ohno, E. Stephen Buescher, Robert L. Roberts, Blood	1986	64
Treatment of chronic recurrent multifocal osteomyelitis with interferon gamma Kerry Gallagher, Robert L. Roberts, J. Macfarlane, The Journal of Pediatrics Interferon GammaSystemic TreatmentPathologyMedicineOrthopaedic Surgery	1997	59

Page 1